Background and Objectives: In addition to left ventricular (LV) functions, right ventricular
(RV) functions and pulmonary arterial stiffness (PAS) may be adversely affected in patients …

The sacubitril/valsartan combination is an important agent used in the treatment of heart
failure with reduced ejection fraction (HFrEF). Pulmonary artery stiffness (PAS) is an index …

Background Pulmonary hypertension (PH) is one of the complications of human
immunodeficiency virus (HIV) infection. Despite the emergence of effective therapies …

Objective Systemic lupus erythematosus (SLE) can present limitations to exercise capacity
and quality of life (QoL) because of various clinical conditions, such as pulmonary disease …

Background There are limited studies on the effects of asthma on cardiac function. Right
ventricular dysfunction and pulmonary hypertension are cardiovascular complications that …

Objective To investigate whether obstructive sleep apnea syndrome (OSAS) has any effect
on pulmonary artery stiffness (PAS) derived from echocardiographic calculation. Methods …

Objective Pulmonary complications are common in patients with liver cirrhosis. Devolopment
of pulmonary hypertension (PH) is associated with a poor prognosis in these patients …

В руководстве представлены основные заболевания и синдромы, проявляющиеся
поражением интерстициальной ткани легких и рентгенологическим синдромом …

Objective: Childhood obesity is associated with cardiovascular risk factors. Being at risk for
overweight has been defined as having a body mass index (BMI) between the 85th and 94th …

Introduction In the current literature, several studies show that PAS (pulmonary artery
stiffness) is associated with RV (right ventricular) dysfunction, PAH (pulmonary arterial …